100. "Modern science should indeed arouse in all of us a humility before the immensity of the unexplored and a tolerance for crazy hypotheses."

-Martin Gardner








The Research Agenda






Ongoing research under IfHI sponsorship is currently investigating the effect of ABO blood groups and soluable endothelial adhesion factors and a possible cause of atherogenesis. This study is currently in progress at the Southwest College of Naturopathic Medicine.


The IfHI research faculty is currently developing study protocols to evaluate the following questions.

  • What is the role of  lectins and immuno-therapeutics in sample patient population previously vaccinated with smallpox?
  • What are cost-effective and practical methods of evaluating effects of lectins and immuno-therapeutics?
  • What is the role of lectin manipulation and chronic inflammatory conditions?
  • Are the differences in soluble cell adhesion molecule levels known to influenced by diet predictable by ABO and secretor genotype?
  • What symptoms specific questionnaire can reliably and consistently measure the effects of dietary lectins?
  • Can circulating levels of anti-Thomsen Friedenreich antibodies be enhanced by diet?
  • Are difference in blood coagulation predictable by ABO genotype a reliable indicator of effective stress management?
  • What are the effects of dietary lectins on serum insulin levels?
  • What are the effects of ABO polymorphism and secretor genotype on hepatitis C progression?
  • What is the clinical relevance of known botanical mediators of ICAM expression on the management of diabetes in individuals of varying ABO blood groups?
  • What are the predictive linkage relationships and lectin reactivities in colonic metaplasia?
  • What are the effects of targeted probiotic therapy as per ABO and secretor genotypes?
  • What symptoms specific questionnaire can reliably and consistently measure the effect of treating disease conditions with dietary lectins?
  • What clinical outcomes adequately evaluates efficacy/treatment response of dietary lectins in chronic diseases?
  • What is the correlation of genetic polymorphism, lectins, disease condition/manifestation, and treatment outcome?
  • What is the most effective treatment protocol applying the principles of human individuality and dietary lectins?
  • What is the role of addressing human individuality and complementary/alternative medicine therapies?